Cameroon vs Haiti: Antiretroviral therapy coverage for PMTCT
Cameroon
59.0%
in 2024
Haiti
60.0%
in 2024
Cameroon rank
62nd
Haiti rank
61st
Antiretroviral therapy coverage for PMTCT over time
- Cameroon
- Haiti
How they compare
Haiti currently reports 60.0% against 59.0% in Cameroon, a difference of 1.0%.
The two have swapped places 8 times across 25 shared years of data; in 2000 it was Haiti ahead.
Cameroon ranks 62nd and Haiti ranks 61st of 84 countries.
Across the 3 decades both report, Cameroon averaged higher in 1 and Haiti in 2.
Head to head by decade
| Decade | Cameroon | Haiti | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.7% | 18.0% | 3.3% | Haiti |
| 2010s | 79.6% | 88.1% | 8.5% | Haiti |
| 2020s | 74.0% | 71.8% | 2.2% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Cameroon or Haiti?
- Haiti, at 60.0% against 59.0% in Cameroon as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Cameroon and Haiti?
- 1.0%, with Haiti ahead.
- How many years of comparable data are there for Cameroon and Haiti?
- 25 years are reported by both, from 2000 to 2024.
- How do Cameroon and Haiti rank globally for antiretroviral therapy coverage for pmtct?
- Cameroon ranks 62nd and Haiti ranks 61st of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).